Multiple sclerosis (MS) is an autoimmune disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. Being a demyelinating...
172 KB (18,189 words) - 20:25, 20 September 2024
Tumefactive multiple sclerosis is a condition in which the central nervous system of a person has multiple demyelinating lesions with atypical characteristics...
34 KB (4,286 words) - 01:29, 13 September 2024
Nucleus Node of Ranvier Axon terminal Schwann cell Myelin sheath Multiple sclerosis is an inflammatory demyelinating disease of the CNS in which activated...
76 KB (9,025 words) - 04:22, 25 March 2024
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS). Several therapies for it exist,...
131 KB (14,020 words) - 17:31, 18 September 2024
Multiple Sclerosis Society may refer to: The Multiple Sclerosis Society of Great Britain The Multiple Sclerosis Society of Canada The National Multiple...
308 bytes (65 words) - 10:21, 4 September 2015
The signs and symptoms of multiple sclerosis (MS) encompass a wide range of neurological and physical manifestations, including vision problems, muscle...
75 KB (8,235 words) - 03:24, 15 August 2024
acute multiple sclerosis, also known as Marburg multiple sclerosis or acute fulminant multiple sclerosis, is considered one of the multiple sclerosis borderline...
9 KB (808 words) - 05:12, 13 December 2023
There are several ways for pharmaceuticals for treating multiple sclerosis (MS) to reach the market. Novel pharmaceuticals cannot enter the US market without...
83 KB (9,405 words) - 11:49, 23 August 2024
Current standards for diagnosing multiple sclerosis (MS) are based on the 2018 revision of McDonald criteria. They rely on MRI detection (or clinical demonstration)...
32 KB (3,285 words) - 19:50, 14 June 2024
Multiple sclerosis (MS) can be pathologically defined as the presence of distributed glial scars (scleroses) in the central nervous system that must show...
143 KB (17,202 words) - 04:12, 17 July 2024